CRYO CELL INTERNATIONAL INC Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
Cryo Cell International Inc quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q3 2010 to Q2 2024.
  • Cryo Cell International Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending May 31, 2024 was $1.47M, a 325% increase year-over-year.
  • Cryo Cell International Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending May 31, 2024 was -$12.7M, a 548% decline year-over-year.
  • Cryo Cell International Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was -$13.4M, a 503% decline from 2022.
  • Cryo Cell International Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was $3.32M, a 27.1% increase from 2021.
  • Cryo Cell International Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was $2.61M, a 48.2% decline from 2020.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$12.7M $1.47M +$1.13M +325% Mar 1, 2024 May 31, 2024 10-Q 2024-07-15
Q1 2024 -$13.8M $795K -$420K -34.6% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-15
Q4 2023 -$13.4M -$16M -$16.6M -2669% Sep 1, 2023 Nov 30, 2023 10-K 2024-02-28
Q3 2023 $3.25M $1.07M +$427K +66.6% Jun 1, 2023 Aug 31, 2023 10-Q 2023-10-12
Q2 2023 $2.82M $346K -$553K -61.5% Mar 1, 2023 May 31, 2023 10-Q 2024-07-15
Q1 2023 $3.38M $1.21M +$58.8K +5.09% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-15
Q4 2022 $3.32M $623K +$1.87M Sep 1, 2022 Nov 30, 2022 10-K 2024-02-28
Q3 2022 $1.45M $641K -$620K -49.2% Jun 1, 2022 Aug 31, 2022 10-Q 2023-10-12
Q2 2022 $2.07M $900K -$741K -45.2% Mar 1, 2022 May 31, 2022 10-Q 2023-07-14
Q1 2022 $2.81M $1.16M +$203K +21.3% Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-21
Q4 2021 $2.61M -$1.24M Sep 1, 2021 Nov 30, 2021 10-K 2023-02-28
Q3 2021 $1.26M Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-18
Q2 2021 $1.64M Mar 1, 2021 May 31, 2021 10-Q 2022-07-11
Q1 2021 $952K Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-13
Q4 2016 -$2.48M $347K +$843K Sep 1, 2016 Nov 30, 2016 10-K 2017-02-28
Q3 2016 -$3.32M -$3.54M -$4.44M -495% Jun 1, 2016 Aug 31, 2016 10-Q 2016-10-17
Q2 2016 $1.12M $839K +$603K +256% Mar 1, 2016 May 31, 2016 10-Q 2016-07-11
Q1 2016 $515K -$123K -$435K -139% Dec 1, 2015 Feb 29, 2016 10-Q 2016-04-14
Q4 2015 $950K -$496K -$225K -83.3% Sep 1, 2015 Nov 30, 2015 10-K 2017-02-28
Q3 2015 $1.17M $898K +$636K +243% Jun 1, 2015 Aug 31, 2015 10-Q 2016-10-17
Q2 2015 $539K $235K -$5.74K -2.38% Mar 1, 2015 May 31, 2015 10-Q 2016-07-11
Q1 2015 $544K $312K -$133K -29.9% Dec 1, 2014 Feb 28, 2015 10-Q 2016-04-14
Q4 2014 $677K -$270K -$145K -116% Sep 1, 2014 Nov 30, 2014 10-K 2016-02-29
Q3 2014 $822K $262K +$25.2K +10.6% Jun 1, 2014 Aug 31, 2014 10-Q 2015-10-15
Q2 2014 $797K $241K +$442K Mar 1, 2014 May 31, 2014 10-Q 2015-07-15
Q1 2014 $355K $444K +$158K +55.2% Dec 1, 2013 Feb 28, 2014 10-Q 2014-04-14
Q4 2013 $197K -$125K +$687K +84.6% Sep 1, 2013 Nov 30, 2013 10-K 2015-03-02
Q3 2013 -$490K $237K +$739K Jun 1, 2013 Aug 31, 2013 10-Q 2014-10-15
Q2 2013 -$1.23M -$201K +$1.28M +86.4% Mar 1, 2013 May 31, 2013 10-Q 2014-07-03
Q1 2013 -$2.51M $286K +$1.91M Dec 1, 2012 Feb 28, 2013 10-Q 2014-04-14
Q4 2012 -$4.42M -$812K -$751K -1234% Sep 1, 2012 Nov 30, 2012 10-K 2014-02-28
Q3 2012 -$3.67M -$502K +$1.84M +78.6% Jun 1, 2012 Aug 31, 2012 10-Q 2013-10-15
Q2 2012 -$5.51M -$1.48M -$1.69M -811% Mar 1, 2012 May 31, 2012 10-Q 2013-07-15
Q1 2012 -$3.82M -$1.62M -$1.9M -697% Dec 1, 2011 Feb 29, 2012 10-Q 2013-04-15
Q4 2011 -$1.92M -$60.9K Sep 1, 2011 Nov 30, 2011 10-K 2013-02-28
Q3 2011 -$2.34M -$2.96M -482% Jun 1, 2011 Aug 31, 2011 10-Q 2012-10-15
Q2 2011 $208K Mar 1, 2011 May 31, 2011 10-Q 2012-07-16
Q1 2011 $272K Dec 1, 2010 Feb 28, 2011 10-Q 2012-04-16
Q3 2010 $614K Jun 1, 2010 Aug 31, 2010 10-Q/A 2011-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.